Souvik Sen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Souvik Sen has a total of 281 co-authors. Here are the top co-authors by number of shared publications:
Stefanie Wood
Department of Neurology, University of South Carolina School of Medicine
6 shared publicationsJames Beck
Division of Comprehensive Oral Health/Periodontology, University of North Carolina, Chapel Hill, North Carolina, USA
5 shared publicationsKevin Moss
Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN
5 shared publicationsLauren Giamberardino
Department of Neurology, Prisma Health Richland, University of South Carolina School of Medicine, Columbia, South Carolina, USA
5 shared publicationsRachel Mascari
Department of Neurology, University of South Carolina School of Medicine, Columbia, South Carolina, USA
5 shared publicationsRebecca F. Gottesman
Stroke Branch, National Institute of Neurological Disorders and Stroke Intramural Research Program, Bethesda, Maryland, USA
5 shared publications
Latest Publications
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19) , e047114
Stroke Burden Attributable to Risk Factors in the Americas, 1990 to 2021: A Temporal Trends Analysis From the GBD Study 2021
Background: Stroke burden varies across the Americas, yet data on modifiable risk factor contributions remain limited. Methods: Using GBD (Global Burden of Disease) study 2021 data, we analyzed stroke mortality and disability‐adjusted life‐year (DALY) rates attributable to 23 modifiable risk factors across 39 countries and territories in the Americas. Age‐standardized rates were compared by sex, stroke subtype, region, and Socio‐Demographic Index; age‐specific estimates used 5‐year groups (25–95+ years). Trends were assessed using average annual percentage change (AAPC) from Joinpoint regression. Results: In 2021, 78.8% (95% uncertainty interval, 70.1%–85.9%) of stroke deaths and 76.9% (68.2%–83.6%) of DALYs were attributable to the 23 risk factors combined. High systolic blood pressure was the leading contributor, accounting for 20.87 attributable deaths (95% uncertainty interval, 15.17–25.80) and 453.30 DALYs (333.16–556.41) per 100 000, representing 54.8% of deaths and 52.2% of DALYs. From 1990 to 2021, the largest reductions occurred for household air pollution from solid fuels (deaths AAPC, −5.09% [95% CI, −5.17 to −5.02]; DALYs AAPC, −4.92% [−4.98 to −4.86]) and secondhand smoke (deaths AAPC, −3.45% [−3.49 to −3.41]). Reductions were minimal for high body mass index (deaths AAPC, −0.54% [−0.59 to −0.49]; DALYs AAPC, −0.42% [−0.46 to −0.37]), high fasting plasma glucose (deaths AAPC, −1.10% [−1.14 to −1.06]), and dietary risks; high body mass index burden increased in the Caribbean, notably in Haiti and the Dominican Republic. Stroke deaths attributable to high temperature increased >3.5% annually (AAPC) in Panama, Jamaica, and the Dominican Republic. High systolic blood pressure burden remained highly unequal, with age‐standardized death rates of 10.42 per 100 000 in high–Socio‐Demographic Index versus 109.33 in low–Socio‐Demographic Index countries. Conclusions: Stroke burden attributable to modifiable risk factors declined overall, but marked disparities persisted. High systolic blood pressure remained dominant, whereas stalled or increasing burden from obesity, metabolic, and dietary risks highlights the need for equity‐focused prevention across the Americas.
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19) , e047114
Stroke Burden Attributable to Risk Factors in the Americas, 1990 to 2021: A Temporal Trends Analysis From the GBD Study 2021
Background: Stroke burden varies across the Americas, yet data on modifiable risk factor contributions remain limited. Methods: Using GBD (Global Burden of Disease) study 2021 data, we analyzed stroke mortality and disability‐adjusted life‐year (DALY) rates attributable to 23 modifiable risk factors across 39 countries and territories in the Americas. Age‐standardized rates were compared by sex, stroke subtype, region, and Socio‐Demographic Index; age‐specific estimates used 5‐year groups (25–95+ years). Trends were assessed using average annual percentage change (AAPC) from Joinpoint regression. Results: In 2021, 78.8% (95% uncertainty interval, 70.1%–85.9%) of stroke deaths and 76.9% (68.2%–83.6%) of DALYs were attributable to the 23 risk factors combined. High systolic blood pressure was the leading contributor, accounting for 20.87 attributable deaths (95% uncertainty interval, 15.17–25.80) and 453.30 DALYs (333.16–556.41) per 100 000, representing 54.8% of deaths and 52.2% of DALYs. From 1990 to 2021, the largest reductions occurred for household air pollution from solid fuels (deaths AAPC, −5.09% [95% CI, −5.17 to −5.02]; DALYs AAPC, −4.92% [−4.98 to −4.86]) and secondhand smoke (deaths AAPC, −3.45% [−3.49 to −3.41]). Reductions were minimal for high body mass index (deaths AAPC, −0.54% [−0.59 to −0.49]; DALYs AAPC, −0.42% [−0.46 to −0.37]), high fasting plasma glucose (deaths AAPC, −1.10% [−1.14 to −1.06]), and dietary risks; high body mass index burden increased in the Caribbean, notably in Haiti and the Dominican Republic. Stroke deaths attributable to high temperature increased >3.5% annually (AAPC) in Panama, Jamaica, and the Dominican Republic. High systolic blood pressure burden remained highly unequal, with age‐standardized death rates of 10.42 per 100 000 in high–Socio‐Demographic Index versus 109.33 in low–Socio‐Demographic Index countries. Conclusions: Stroke burden attributable to modifiable risk factors declined overall, but marked disparities persisted. High systolic blood pressure remained dominant, whereas stalled or increasing burden from obesity, metabolic, and dietary risks highlights the need for equity‐focused prevention across the Americas.
- Open Access
- 1 October 2026
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 216, 111948
A contactless and AI-assisted sensor for gait assessment of stroke patients
- 1 October 2026
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 216, 111948
Open AccessA contactless and AI-assisted sensor for gait assessment of stroke patients
- 16 September 2026
- Published by Wiley in Journal of Periodontal Research
Periodontitis, Tooth Loss, and Risk of Cognitive Impairment and Dementia: A Systematic Review With Meta‐Analysis
Aim: To systematically review and meta‐analyze cohort studies evaluating associations of gingival inflammation, periodontitis, and tooth loss with cognitive decline and incident mild cognitive impairment or dementia. Methods: PROSPERO‐registered searches of MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library identified cohort studies from inception through October 10, 2025, with a PubMed update on June 24, 2026. Random‐effects meta‐analyses pooled adjusted hazard ratios (HRs) for dementia/MCI; cognitive function outcomes were summarized qualitatively. Risk of bias (RoB) was assessed using the Newcastle–Ottawa Scale. Results: Fifty‐nine studies met inclusion criteria; 28 contributed to dementia/MCI meta‐analyses. Severe periodontitis (HR: 1.16; 95% CI: 1.06–1.27; I 2 = 0%; Q ‐test p = 0.49), periodontitis of unspecified severity (HR: 1.45; 95% CI: 1.21–1.73; I 2 = 98%; Q ‐test p < 0.001), edentulism (HR: 1.26; 95% CI: 1.19–1.33), and low tooth count (HR: 1.27; 95% CI: 1.14–1.42; I 2 = 94%; Q ‐test p < 0.001) were associated with elevated dementia/MCI risk. RoB was low in 31 studies (53%), moderate in 25 (42%), and high in 3 (5%); inadequate confounder adjustment was common. Meta‐regression showed stronger estimates for ICD‐code periodontitis definitions (fold change (FC) = 1.44 95% CI: 1.04–2.01), older cohorts (FC per year = 1.02 95% CI: 1.00, 1.05), and weaker estimates with lower RoB (FC per NOS star = 0.81 95% CI: 0.73–0.92). Follow‐up duration, cohort age, and RoB were not associated with tooth‐count estimates. Conclusion: Periodontitis and tooth loss are associated with modestly higher dementia/MCI risk and poorer cognitive function, but heterogeneity, residual confounding, and bias temper causal interpretation. Longitudinal studies with rigorous baseline cognition assessment and intervention studies are needed.
- 16 September 2026
- Published by Wiley in Journal of Periodontal Research
Periodontitis, Tooth Loss, and Risk of Cognitive Impairment and Dementia: A Systematic Review With Meta‐Analysis
Aim: To systematically review and meta‐analyze cohort studies evaluating associations of gingival inflammation, periodontitis, and tooth loss with cognitive decline and incident mild cognitive impairment or dementia. Methods: PROSPERO‐registered searches of MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library identified cohort studies from inception through October 10, 2025, with a PubMed update on June 24, 2026. Random‐effects meta‐analyses pooled adjusted hazard ratios (HRs) for dementia/MCI; cognitive function outcomes were summarized qualitatively. Risk of bias (RoB) was assessed using the Newcastle–Ottawa Scale. Results: Fifty‐nine studies met inclusion criteria; 28 contributed to dementia/MCI meta‐analyses. Severe periodontitis (HR: 1.16; 95% CI: 1.06–1.27; I 2 = 0%; Q ‐test p = 0.49), periodontitis of unspecified severity (HR: 1.45; 95% CI: 1.21–1.73; I 2 = 98%; Q ‐test p < 0.001), edentulism (HR: 1.26; 95% CI: 1.19–1.33), and low tooth count (HR: 1.27; 95% CI: 1.14–1.42; I 2 = 94%; Q ‐test p < 0.001) were associated with elevated dementia/MCI risk. RoB was low in 31 studies (53%), moderate in 25 (42%), and high in 3 (5%); inadequate confounder adjustment was common. Meta‐regression showed stronger estimates for ICD‐code periodontitis definitions (fold change (FC) = 1.44 95% CI: 1.04–2.01), older cohorts (FC per year = 1.02 95% CI: 1.00, 1.05), and weaker estimates with lower RoB (FC per NOS star = 0.81 95% CI: 0.73–0.92). Follow‐up duration, cohort age, and RoB were not associated with tooth‐count estimates. Conclusion: Periodontitis and tooth loss are associated with modestly higher dementia/MCI risk and poorer cognitive function, but heterogeneity, residual confounding, and bias temper causal interpretation. Longitudinal studies with rigorous baseline cognition assessment and intervention studies are needed.
- Open Access
- 2 September 2026
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 3 (4)
Endothelium-targeted and untargeted nanoparticle therapies in thromboinflammatory vascular diseases
- 2 September 2026
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 3 (4)
Open AccessEndothelium-targeted and untargeted nanoparticle therapies in thromboinflammatory vascular diseases
- 1 September 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (17)
Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk Factor: A Randomized Trial
Background: Individuals residing in the southeastern United States experience disproportionately worse stroke outcomes. Although blood pressure ( BP ) reduction is among the most effective strategies for improving stroke outcomes, fewer than one third of survivors of stroke achieve BP control within 1 year of the index event. Methods: The PACESETTER (Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk Factor) trial enrolled patients with stroke and uncontrolled BP from 3 safety‐net health care systems in South Carolina. Patients were randomized 1:1 to the PACESETTER intervention, which included a Bluetooth‐enabled electronic pill tray, a BP monitor, and a smartphone application for automated data transmission of medication adherence and BP data to a central server or to usual care. The primary outcome was systolic BP P =0.07), but no significant difference was observed at 12 months (50% versus 47.2%, P =0.82). Conclusions: Because the trial was terminated prematurely, the effect of the PACESETTER intervention on 12‐month BP control after stroke remains uncertain. A trial completed to its full term and sufficiently powered to also evaluate key short‐term end points is needed. Registration: URL: https://www.clinicalstrial.org ; Unique Identifier: NCT03401489.
- 1 September 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (17)
Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk Factor: A Randomized Trial
Background: Individuals residing in the southeastern United States experience disproportionately worse stroke outcomes. Although blood pressure ( BP ) reduction is among the most effective strategies for improving stroke outcomes, fewer than one third of survivors of stroke achieve BP control within 1 year of the index event. Methods: The PACESETTER (Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk Factor) trial enrolled patients with stroke and uncontrolled BP from 3 safety‐net health care systems in South Carolina. Patients were randomized 1:1 to the PACESETTER intervention, which included a Bluetooth‐enabled electronic pill tray, a BP monitor, and a smartphone application for automated data transmission of medication adherence and BP data to a central server or to usual care. The primary outcome was systolic BP P =0.07), but no significant difference was observed at 12 months (50% versus 47.2%, P =0.82). Conclusions: Because the trial was terminated prematurely, the effect of the PACESETTER intervention on 12‐month BP control after stroke remains uncertain. A trial completed to its full term and sufficiently powered to also evaluate key short‐term end points is needed. Registration: URL: https://www.clinicalstrial.org ; Unique Identifier: NCT03401489.
- Open Access
- 7 July 2026
- Published by Frontiers Media SA in Frontiers in Stroke
- Vol. 5, 1807730
Age, race, and education as moderators of post-stroke cognitive decline following dental care
Post-stroke cognitive decline (PSCD) poses a significant challenge to long-term recovery and quality of life following stroke, influenced by both fixed biological factors and modifiable health behaviors such as oral and dental care. In this data-driven exploratory analysis of the PREMIERS Phase II randomized trial ( ClinicalTrials.gov NCT#02541032), we examined the moderating effects of clinical, biological, and demographic characteristics on the relationship between dental care and PSCD over a 12-month period. The study included 280 stroke/transient ischemic attack (TIA) survivors who received either intensive or standard dental care. Cognitive outcomes were assessed using the Montreal Cognitive Assessment (MoCA) at baseline and follow-up, with change in MoCA score as the primary outcome. Lasso regression was applied for empirically based feature selection of moderators, and bootstrapped multiple linear regression demonstrated that increased dental visits predicted relatively better cognitive outcomes in older adults (age interaction-term b = −0.664, p < 0.001), Black participants (race interaction-term b = −0.475, p < 0.05), and those with low-intermediate education levels (education interaction-term b = 0.413, p < 0.05). Exploratory graphs revealed that older adults, Black adults, and adults with low-intermediate education showed greater cognitive improvement with higher dental visit frequency, with the final model (including selected moderators) significantly predicting PSCD [ F (11, 268) = 10.51, p < 0.001]. These findings highlight the potential of equity-focused, precision-medicine interventions that incorporate dental care to mitigate PSCD in vulnerable stroke populations.
- 7 July 2026
- Published by Frontiers Media SA in Frontiers in Stroke
- Vol. 5, 1807730
Open AccessAge, race, and education as moderators of post-stroke cognitive decline following dental care
Post-stroke cognitive decline (PSCD) poses a significant challenge to long-term recovery and quality of life following stroke, influenced by both fixed biological factors and modifiable health behaviors such as oral and dental care. In this data-driven exploratory analysis of the PREMIERS Phase II randomized trial ( ClinicalTrials.gov NCT#02541032), we examined the moderating effects of clinical, biological, and demographic characteristics on the relationship between dental care and PSCD over a 12-month period. The study included 280 stroke/transient ischemic attack (TIA) survivors who received either intensive or standard dental care. Cognitive outcomes were assessed using the Montreal Cognitive Assessment (MoCA) at baseline and follow-up, with change in MoCA score as the primary outcome. Lasso regression was applied for empirically based feature selection of moderators, and bootstrapped multiple linear regression demonstrated that increased dental visits predicted relatively better cognitive outcomes in older adults (age interaction-term b = −0.664, p < 0.001), Black participants (race interaction-term b = −0.475, p < 0.05), and those with low-intermediate education levels (education interaction-term b = 0.413, p < 0.05). Exploratory graphs revealed that older adults, Black adults, and adults with low-intermediate education showed greater cognitive improvement with higher dental visit frequency, with the final model (including selected moderators) significantly predicting PSCD [ F (11, 268) = 10.51, p < 0.001]. These findings highlight the potential of equity-focused, precision-medicine interventions that incorporate dental care to mitigate PSCD in vulnerable stroke populations.
- 1 May 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (5) , 1273-1282
Dental Flossing May Lower the Risk for Incident Ischemic Stroke, Cardioembolic Stroke Subtype, and Atrial Fibrillation
BACKGROUND: Prior studies have demonstrated an association between oral infection and both incident stroke and atrial fibrillation (AF), a major cause of cardioembolic stroke. However, the impact of preventive oral behaviors such as dental flossing on incident stroke and AF remains unclear. We evaluated the relationship between flossing, incident stroke subtypes, and AF from the ARIC study (Atherosclerosis Risk in Communities). METHODS: We conducted a prospective cohort study using data from the ARIC study. Flossing was assessed via a structured questionnaire at visit 4 (1996–1998). Participants were censored at the first stroke, death, or loss-to-follow-up through December 31, 2021. Incident ischemic stroke and subtypes were evaluated using Cox proportional hazards models, adjusting for cardiovascular risk factors, education, regular brushing, dental care utilization, periodontal disease, and dental caries. RESULTS: Among 6200 dentate participants without prior stroke, 65% (n=4049) reported regular flossing. Flossers had significantly lower prevalence of vascular risk factors, periodontal disease, and dental caries at baseline. Flossers had lower IL (interleukin)-6 levels in crude analysis, but this difference was explained by confounding from age, body mass index, and smoking. CRP (C-reactive protein) levels did not differ between groups. During a median 23.7 years follow-up, 434 ischemic strokes occurred, including 146 thrombotic, 102 cardioembolic, 95 lacunar, and 91 other ischemic subtypes. Nonflossers had higher rates of both ischemic stroke (8.7% versus 6.1%) and nonstroke mortality (40.8% versus 34.5%). Flossing was associated with lower risk of ischemic stroke (adjusted hazard ratio, 0.77 [95% CI, 0.64–0.96]), cardioembolic stroke (adjusted hazard ratio, 0.60 [95% CI, 0.38–0.94]), and AF (adjusted hazard ratio, 0.88 [95% CI, 0.77–0.99]) with dose-response relationship ( P trend=0.001) 6.6% of the effect mediated by lower AF incidence. Results remained robust in competing risk analysis (adjusted hazard ratio, 0.79 [95% CI, 0.63–0.98]) with an E value of 1.87. CONCLUSIONS: Regular flossing was associated with a lower risk of ischemic stroke, primarily driven by reductions in cardioembolic stroke and AF, independent of other oral health behaviors. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00005131.
- 1 May 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (5) , 1273-1282
Dental Flossing May Lower the Risk for Incident Ischemic Stroke, Cardioembolic Stroke Subtype, and Atrial Fibrillation
BACKGROUND: Prior studies have demonstrated an association between oral infection and both incident stroke and atrial fibrillation (AF), a major cause of cardioembolic stroke. However, the impact of preventive oral behaviors such as dental flossing on incident stroke and AF remains unclear. We evaluated the relationship between flossing, incident stroke subtypes, and AF from the ARIC study (Atherosclerosis Risk in Communities). METHODS: We conducted a prospective cohort study using data from the ARIC study. Flossing was assessed via a structured questionnaire at visit 4 (1996–1998). Participants were censored at the first stroke, death, or loss-to-follow-up through December 31, 2021. Incident ischemic stroke and subtypes were evaluated using Cox proportional hazards models, adjusting for cardiovascular risk factors, education, regular brushing, dental care utilization, periodontal disease, and dental caries. RESULTS: Among 6200 dentate participants without prior stroke, 65% (n=4049) reported regular flossing. Flossers had significantly lower prevalence of vascular risk factors, periodontal disease, and dental caries at baseline. Flossers had lower IL (interleukin)-6 levels in crude analysis, but this difference was explained by confounding from age, body mass index, and smoking. CRP (C-reactive protein) levels did not differ between groups. During a median 23.7 years follow-up, 434 ischemic strokes occurred, including 146 thrombotic, 102 cardioembolic, 95 lacunar, and 91 other ischemic subtypes. Nonflossers had higher rates of both ischemic stroke (8.7% versus 6.1%) and nonstroke mortality (40.8% versus 34.5%). Flossing was associated with lower risk of ischemic stroke (adjusted hazard ratio, 0.77 [95% CI, 0.64–0.96]), cardioembolic stroke (adjusted hazard ratio, 0.60 [95% CI, 0.38–0.94]), and AF (adjusted hazard ratio, 0.88 [95% CI, 0.77–0.99]) with dose-response relationship ( P trend=0.001) 6.6% of the effect mediated by lower AF incidence. Results remained robust in competing risk analysis (adjusted hazard ratio, 0.79 [95% CI, 0.63–0.98]) with an E value of 1.87. CONCLUSIONS: Regular flossing was associated with a lower risk of ischemic stroke, primarily driven by reductions in cardioembolic stroke and AF, independent of other oral health behaviors. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00005131.
- 1 May 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (5) , 1418-1427
From Gums to Brain: Unveiling the Hidden Inflammatory Connection Between Periodontal and Cerebrovascular Diseases
Periodontal disease (PD) encompasses inflammatory conditions affecting the supporting structures of the teeth, with gingivitis and periodontitis being the most prevalent forms. Gingivitis, characterized by gum inflammation and bleeding, can progress to periodontitis, which involves the destruction of connective tissue and alveolar bone. PD is a global health burden, affecting over a billion individuals, with 42.2% of adults aged ≥30 years in the United States experiencing some form of periodontitis. Without proper management, PD can lead to severe systemic consequences. The cause of PD is multifactorial, involving bacterial biofilm, systemic diseases, aging, smoking, high-fat diets, and immune deficiencies. These risk factors act independently or synergistically, accelerating disease progression. Prevention and treatment strategies focus on biofilm control, nonsurgical therapy, improved oral hygiene, and risk factor management to halt disease progression and restore tooth support. Recent research suggests a strong link between PD and cardiovascular diseases, including stroke, due to systemic inflammation. Periodontitis-induced inflammation triggers the release of cytokines and CRP (C-reactive protein), which can enter systemic circulation, promoting atherosclerosis and endothelial dysfunction. Bacterial translocation from the oral cavity into the bloodstream further exacerbates vascular disease, increasing stroke risk. Epidemiological studies indicate that individuals with periodontitis have a significantly higher risk of stroke, with case-control and cohort studies showing strong associations. However, some interventional studies suggest that periodontal treatment alone may not significantly reduce cardiovascular events, highlighting the complexity of this relationship. This review aimed to summarize existing literature on the association between PD and cerebrovascular diseases, emphasizing underlying pathophysiological mechanisms and epidemiological evidence.
- 1 May 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (5) , 1418-1427
From Gums to Brain: Unveiling the Hidden Inflammatory Connection Between Periodontal and Cerebrovascular Diseases
Periodontal disease (PD) encompasses inflammatory conditions affecting the supporting structures of the teeth, with gingivitis and periodontitis being the most prevalent forms. Gingivitis, characterized by gum inflammation and bleeding, can progress to periodontitis, which involves the destruction of connective tissue and alveolar bone. PD is a global health burden, affecting over a billion individuals, with 42.2% of adults aged ≥30 years in the United States experiencing some form of periodontitis. Without proper management, PD can lead to severe systemic consequences. The cause of PD is multifactorial, involving bacterial biofilm, systemic diseases, aging, smoking, high-fat diets, and immune deficiencies. These risk factors act independently or synergistically, accelerating disease progression. Prevention and treatment strategies focus on biofilm control, nonsurgical therapy, improved oral hygiene, and risk factor management to halt disease progression and restore tooth support. Recent research suggests a strong link between PD and cardiovascular diseases, including stroke, due to systemic inflammation. Periodontitis-induced inflammation triggers the release of cytokines and CRP (C-reactive protein), which can enter systemic circulation, promoting atherosclerosis and endothelial dysfunction. Bacterial translocation from the oral cavity into the bloodstream further exacerbates vascular disease, increasing stroke risk. Epidemiological studies indicate that individuals with periodontitis have a significantly higher risk of stroke, with case-control and cohort studies showing strong associations. However, some interventional studies suggest that periodontal treatment alone may not significantly reduce cardiovascular events, highlighting the complexity of this relationship. This review aimed to summarize existing literature on the association between PD and cerebrovascular diseases, emphasizing underlying pathophysiological mechanisms and epidemiological evidence.
- Open Access
- 1 December 2025
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 1 (4)
Combined Influence of Dental Caries and Periodontal Disease on Ischemic Stroke Risk
Periodontal disease (PD) and dental caries are prevalent chronic oral inflammatory conditions associated with systemic health outcomes. Individually, both have been linked to an increased risk of ischemic stroke, a leading cause of morbidity and mortality. However, few studies have examined the combined effect of PD and dental caries on stroke, stroke subtypes, and major adverse cardiovascular events (MACEs) within US cohorts. We aimed to evaluate the individual and joint associations of PD and dental caries with incident ischemic stroke, stroke subtypes, and MACEs and assess the relationship between regular dental care utilization and oral disease status. We analyzed data from participants in the Atherosclerosis Risk in Communities study who completed dental assessments during Visit 4 (1996–1998). Participants with previous ischemic stroke, coronary heart disease (CHD), or dental caries without PD were excluded. Oral health status was categorized as good oral health, PD only, or PD with(+) caries. Incident ischemic stroke and MACEs (ischemic stroke, myocardial infarction, or fatal CHD) were identified using adjudicated records through 2019. Cox proportional hazard models estimated hazard ratios (HRs) for outcomes, adjusting for demographics and vascular risk factors. The association of regular dental care with oral disease status was analyzed using logistic regression. Among 5,986 participants (mean age 63 ± 5.6 years; 52% female), 1,640 had good oral health, 3,151 had PD only, and 1,195 had PD + caries. The incidence of ischemic stroke was 4.1%, 6.9%, and 10.0% across groups, respectively. In fully adjusted models, PD + caries was associated with increased risk of ischemic stroke (HR 1.86; 95% CI 1.32–2.61) and MACEs (HR 1.36; 95% CI 1.10–1.69). Elevated risk was observed for thrombotic (HR 2.27; 95% CI 1.22–4.24) and cardioembolic (HR 2.58; 95% CI 1.27–5.26) strokes. Regular dental care was associated with lower odds of PD (odds ratio [OR] 0.71; 95% CI 0.58–0.86) and PD + caries (OR 0.19; 95% CI 0.15–0.25). Co-occurring PD and dental caries were independently associated with increased risk of ischemic stroke and MACEs. Regular dental care may reduce this risk by improving oral health. Limitations include reliance on one-time dental assessment and residual confounding.
- 1 December 2025
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 1 (4)
Open AccessCombined Influence of Dental Caries and Periodontal Disease on Ischemic Stroke Risk
Periodontal disease (PD) and dental caries are prevalent chronic oral inflammatory conditions associated with systemic health outcomes. Individually, both have been linked to an increased risk of ischemic stroke, a leading cause of morbidity and mortality. However, few studies have examined the combined effect of PD and dental caries on stroke, stroke subtypes, and major adverse cardiovascular events (MACEs) within US cohorts. We aimed to evaluate the individual and joint associations of PD and dental caries with incident ischemic stroke, stroke subtypes, and MACEs and assess the relationship between regular dental care utilization and oral disease status. We analyzed data from participants in the Atherosclerosis Risk in Communities study who completed dental assessments during Visit 4 (1996–1998). Participants with previous ischemic stroke, coronary heart disease (CHD), or dental caries without PD were excluded. Oral health status was categorized as good oral health, PD only, or PD with(+) caries. Incident ischemic stroke and MACEs (ischemic stroke, myocardial infarction, or fatal CHD) were identified using adjudicated records through 2019. Cox proportional hazard models estimated hazard ratios (HRs) for outcomes, adjusting for demographics and vascular risk factors. The association of regular dental care with oral disease status was analyzed using logistic regression. Among 5,986 participants (mean age 63 ± 5.6 years; 52% female), 1,640 had good oral health, 3,151 had PD only, and 1,195 had PD + caries. The incidence of ischemic stroke was 4.1%, 6.9%, and 10.0% across groups, respectively. In fully adjusted models, PD + caries was associated with increased risk of ischemic stroke (HR 1.86; 95% CI 1.32–2.61) and MACEs (HR 1.36; 95% CI 1.10–1.69). Elevated risk was observed for thrombotic (HR 2.27; 95% CI 1.22–4.24) and cardioembolic (HR 2.58; 95% CI 1.27–5.26) strokes. Regular dental care was associated with lower odds of PD (odds ratio [OR] 0.71; 95% CI 0.58–0.86) and PD + caries (OR 0.19; 95% CI 0.15–0.25). Co-occurring PD and dental caries were independently associated with increased risk of ischemic stroke and MACEs. Regular dental care may reduce this risk by improving oral health. Limitations include reliance on one-time dental assessment and residual confounding.
- Open Access
- 1 December 2025
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 1 (4)
Periodontal Disease Independently Associated With White Matter Hyperintensity Volume
White matter hyperintensities (WMHs), cerebral microbleeds (CMBs), and lacunar infarcts are radiographic markers of cerebral small vessel disease (CSVD), which is associated with an increased risk of stroke and cognitive decline. Periodontal disease (PD), a chronic inflammatory condition, has been linked to vascular pathology and may contribute to CSVD. The aim of this study was to assess the independent association between PD and MRI-verified CSVD features using data from the Atherosclerosis Risk in Communities (ARIC) cohort. Periodontal status was classified as PD (n = 800) or periodontal health ([PH]; n = 343). CSVD features included WMH volume (WMHV), CMBs, and lacunar infarcts. WMHV was derived from fluid-attenuated inversion recovery images and categorized into quartiles. Multinomial logistic regression was used to evaluate associations between PD and WMHV quartiles, and binomial logistic regression assessed associations between PD and the presence of CMBs and lacunar infarcts. Models were adjusted for demographic and vascular risk factors including age, sex, race-center, hypertension, diabetes, smoking status, and time between visits. We analyzed 1,143 ARIC participants (mean age 77 years; 45% male; 76% White, 24% African American) who underwent periodontal assessment at Visit 4 and brain MRI at Visit 5. Participants with PD had significantly greater WMHV compared with those with PH (median WMH%: 2.83 vs 2.52; p = 0.012). PD was associated with the highest WMHV quartile (Q4 >21.36 cm3), with a crude odds ratio (OR) of 1.77 (95% CI 1.23–2.56) and an adjusted OR of 1.56 (95% CI 1.01–2.40). A weak but significant correlation was found between WMHV and World Workshop Periodontal Profile Class (ρ = 0.076, p = 0.011). No statistically significant adjusted associations were found between PD and CMBs (adj. OR 1.16, 95% CI 0.83–1.63) or lacunar infarcts (adj. OR 1.14, 95% CI 0.77–1.69). PD was independently associated with greater WMH burden, a key imaging marker of CSVD, but not with CMBs or lacunar infarcts after adjustment for confounders. This suggests that PD may contribute to CSVD pathology, particularly WMHs, through mechanisms involving systemic inflammation. Limitations include the temporal gap between dental and imaging assessments and potential residual confounding. Interventions targeting PD could be explored as a modifiable risk factor for CSVD prevention.
- 1 December 2025
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 1 (4)
Open AccessPeriodontal Disease Independently Associated With White Matter Hyperintensity Volume
White matter hyperintensities (WMHs), cerebral microbleeds (CMBs), and lacunar infarcts are radiographic markers of cerebral small vessel disease (CSVD), which is associated with an increased risk of stroke and cognitive decline. Periodontal disease (PD), a chronic inflammatory condition, has been linked to vascular pathology and may contribute to CSVD. The aim of this study was to assess the independent association between PD and MRI-verified CSVD features using data from the Atherosclerosis Risk in Communities (ARIC) cohort. Periodontal status was classified as PD (n = 800) or periodontal health ([PH]; n = 343). CSVD features included WMH volume (WMHV), CMBs, and lacunar infarcts. WMHV was derived from fluid-attenuated inversion recovery images and categorized into quartiles. Multinomial logistic regression was used to evaluate associations between PD and WMHV quartiles, and binomial logistic regression assessed associations between PD and the presence of CMBs and lacunar infarcts. Models were adjusted for demographic and vascular risk factors including age, sex, race-center, hypertension, diabetes, smoking status, and time between visits. We analyzed 1,143 ARIC participants (mean age 77 years; 45% male; 76% White, 24% African American) who underwent periodontal assessment at Visit 4 and brain MRI at Visit 5. Participants with PD had significantly greater WMHV compared with those with PH (median WMH%: 2.83 vs 2.52; p = 0.012). PD was associated with the highest WMHV quartile (Q4 >21.36 cm3), with a crude odds ratio (OR) of 1.77 (95% CI 1.23–2.56) and an adjusted OR of 1.56 (95% CI 1.01–2.40). A weak but significant correlation was found between WMHV and World Workshop Periodontal Profile Class (ρ = 0.076, p = 0.011). No statistically significant adjusted associations were found between PD and CMBs (adj. OR 1.16, 95% CI 0.83–1.63) or lacunar infarcts (adj. OR 1.14, 95% CI 0.77–1.69). PD was independently associated with greater WMH burden, a key imaging marker of CSVD, but not with CMBs or lacunar infarcts after adjustment for confounders. This suggests that PD may contribute to CSVD pathology, particularly WMHs, through mechanisms involving systemic inflammation. Limitations include the temporal gap between dental and imaging assessments and potential residual confounding. Interventions targeting PD could be explored as a modifiable risk factor for CSVD prevention.